nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Paclitaxel—ovarian cancer	0.0878	0.137	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0878	0.137	CbGbCtD
Lercanidipine—CYP3A5—Paclitaxel—ovarian cancer	0.0659	0.103	CbGbCtD
Lercanidipine—CYP3A7—Docetaxel—ovarian cancer	0.0635	0.0989	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0635	0.0989	CbGbCtD
Lercanidipine—CYP2D6—Vinorelbine—ovarian cancer	0.0575	0.0896	CbGbCtD
Lercanidipine—CYP3A4—Topotecan—ovarian cancer	0.0519	0.0808	CbGbCtD
Lercanidipine—CYP3A5—Docetaxel—ovarian cancer	0.0476	0.0742	CbGbCtD
Lercanidipine—CYP3A4—Vinorelbine—ovarian cancer	0.0366	0.0569	CbGbCtD
Lercanidipine—CYP3A4—Paclitaxel—ovarian cancer	0.0257	0.04	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—ovarian cancer	0.0218	0.0339	CbGbCtD
Lercanidipine—CYP3A4—Docetaxel—ovarian cancer	0.0186	0.0289	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—ovarian cancer	0.0138	0.0216	CbGbCtD
Lercanidipine—Nisoldipine—ABCB1—ovarian cancer	0.000483	0.243	CrCbGaD
Lercanidipine—Nitrendipine—ABCB1—ovarian cancer	0.000452	0.228	CrCbGaD
Lercanidipine—Felodipine—ABCB1—ovarian cancer	0.00036	0.181	CrCbGaD
Lercanidipine—Nifedipine—ABCB1—ovarian cancer	0.000348	0.175	CrCbGaD
Lercanidipine—Nicardipine—ABCB1—ovarian cancer	0.000343	0.173	CrCbGaD
Lercanidipine—Skin disorder—Paclitaxel—ovarian cancer	0.000331	0.00093	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00033	0.000928	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00033	0.000928	CcSEcCtD
Lercanidipine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000329	0.000926	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000328	0.000922	CcSEcCtD
Lercanidipine—Anaemia—Docetaxel—ovarian cancer	0.000327	0.000919	CcSEcCtD
Lercanidipine—Pancytopenia—Epirubicin—ovarian cancer	0.000325	0.000914	CcSEcCtD
Lercanidipine—Anorexia—Paclitaxel—ovarian cancer	0.000325	0.000913	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000324	0.000909	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—ovarian cancer	0.000324	0.000909	CcSEcCtD
Lercanidipine—Vomiting—Vinorelbine—ovarian cancer	0.000322	0.000905	CcSEcCtD
Lercanidipine—Neutropenia—Epirubicin—ovarian cancer	0.00032	0.0009	CcSEcCtD
Lercanidipine—Rash—Vinorelbine—ovarian cancer	0.000319	0.000898	CcSEcCtD
Lercanidipine—Dermatitis—Vinorelbine—ovarian cancer	0.000319	0.000897	CcSEcCtD
Lercanidipine—Hypotension—Paclitaxel—ovarian cancer	0.000318	0.000895	CcSEcCtD
Lercanidipine—Headache—Vinorelbine—ovarian cancer	0.000317	0.000892	CcSEcCtD
Lercanidipine—Syncope—Docetaxel—ovarian cancer	0.000317	0.000892	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—ovarian cancer	0.000317	0.000891	CcSEcCtD
Lercanidipine—Pollakiuria—Epirubicin—ovarian cancer	0.000317	0.000889	CcSEcCtD
Lercanidipine—Palpitations—Docetaxel—ovarian cancer	0.000313	0.000879	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000313	0.000879	CcSEcCtD
Lercanidipine—Loss of consciousness—Docetaxel—ovarian cancer	0.000311	0.000874	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—ovarian cancer	0.000311	0.000873	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000311	0.000873	CcSEcCtD
Lercanidipine—Cough—Docetaxel—ovarian cancer	0.000309	0.000868	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—ovarian cancer	0.000309	0.000868	CcSEcCtD
Lercanidipine—Insomnia—Paclitaxel—ovarian cancer	0.000308	0.000866	CcSEcCtD
Lercanidipine—Paraesthesia—Paclitaxel—ovarian cancer	0.000306	0.00086	CcSEcCtD
Lercanidipine—Dyspnoea—Paclitaxel—ovarian cancer	0.000304	0.000854	CcSEcCtD
Lercanidipine—Somnolence—Paclitaxel—ovarian cancer	0.000303	0.000851	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000303	0.000851	CcSEcCtD
Lercanidipine—Chest pain—Docetaxel—ovarian cancer	0.000301	0.000847	CcSEcCtD
Lercanidipine—Myalgia—Docetaxel—ovarian cancer	0.000301	0.000847	CcSEcCtD
Lercanidipine—Arthralgia—Docetaxel—ovarian cancer	0.000301	0.000847	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—ovarian cancer	0.000301	0.000846	CcSEcCtD
Lercanidipine—Nausea—Vinorelbine—ovarian cancer	0.000301	0.000846	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—ovarian cancer	0.0003	0.000844	CcSEcCtD
Lercanidipine—Dyspepsia—Paclitaxel—ovarian cancer	0.0003	0.000843	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000299	0.000841	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000299	0.000841	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—ovarian cancer	0.000298	0.000837	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—ovarian cancer	0.000298	0.000837	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—ovarian cancer	0.000296	0.000833	CcSEcCtD
Lercanidipine—Decreased appetite—Paclitaxel—ovarian cancer	0.000296	0.000833	CcSEcCtD
Lercanidipine—Dry mouth—Docetaxel—ovarian cancer	0.000295	0.000828	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000294	0.000827	CcSEcCtD
Lercanidipine—Fatigue—Paclitaxel—ovarian cancer	0.000294	0.000826	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—ovarian cancer	0.000293	0.000823	CcSEcCtD
Lercanidipine—Constipation—Paclitaxel—ovarian cancer	0.000291	0.000819	CcSEcCtD
Lercanidipine—Confusional state—Docetaxel—ovarian cancer	0.000291	0.000818	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000289	0.000813	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000289	0.000812	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—ovarian cancer	0.000285	0.000801	CcSEcCtD
Lercanidipine—Shock—Docetaxel—ovarian cancer	0.000284	0.000799	CcSEcCtD
Lercanidipine—Nervous system disorder—Docetaxel—ovarian cancer	0.000283	0.000796	CcSEcCtD
Lercanidipine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000283	0.000795	CcSEcCtD
Lercanidipine—Tachycardia—Docetaxel—ovarian cancer	0.000282	0.000792	CcSEcCtD
Lercanidipine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000281	0.000789	CcSEcCtD
Lercanidipine—Skin disorder—Docetaxel—ovarian cancer	0.000281	0.000788	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00028	0.000787	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000279	0.000783	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—ovarian cancer	0.000278	0.000781	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000277	0.000779	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—ovarian cancer	0.000276	0.000774	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—ovarian cancer	0.000276	0.000774	CcSEcCtD
Lercanidipine—Anorexia—Docetaxel—ovarian cancer	0.000275	0.000774	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—ovarian cancer	0.000275	0.000773	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—ovarian cancer	0.000274	0.000771	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000271	0.000761	CcSEcCtD
Lercanidipine—Urticaria—Paclitaxel—ovarian cancer	0.000271	0.000761	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—ovarian cancer	0.00027	0.000759	CcSEcCtD
Lercanidipine—Hypotension—Docetaxel—ovarian cancer	0.00027	0.000759	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00027	0.000757	CcSEcCtD
Lercanidipine—Abdominal pain—Paclitaxel—ovarian cancer	0.000269	0.000757	CcSEcCtD
Lercanidipine—Body temperature increased—Paclitaxel—ovarian cancer	0.000269	0.000757	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—ovarian cancer	0.000269	0.000755	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000267	0.000751	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000264	0.000741	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000263	0.00074	CcSEcCtD
Lercanidipine—Insomnia—Docetaxel—ovarian cancer	0.000261	0.000734	CcSEcCtD
Lercanidipine—Paraesthesia—Docetaxel—ovarian cancer	0.000259	0.000729	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—ovarian cancer	0.000259	0.000729	CcSEcCtD
Lercanidipine—Dyspnoea—Docetaxel—ovarian cancer	0.000258	0.000724	CcSEcCtD
Lercanidipine—Somnolence—Docetaxel—ovarian cancer	0.000257	0.000722	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—ovarian cancer	0.000256	0.00072	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—ovarian cancer	0.000256	0.000719	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—ovarian cancer	0.000255	0.000715	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—ovarian cancer	0.000255	0.000715	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—ovarian cancer	0.000254	0.000715	CcSEcCtD
Lercanidipine—Dyspepsia—Docetaxel—ovarian cancer	0.000254	0.000715	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—ovarian cancer	0.000254	0.000713	CcSEcCtD
Lercanidipine—Decreased appetite—Docetaxel—ovarian cancer	0.000251	0.000706	CcSEcCtD
Lercanidipine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000251	0.000706	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000251	0.000704	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00025	0.000702	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000249	0.000701	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000249	0.000701	CcSEcCtD
Lercanidipine—Fatigue—Docetaxel—ovarian cancer	0.000249	0.0007	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—ovarian cancer	0.000249	0.000699	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—ovarian cancer	0.000249	0.000699	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—ovarian cancer	0.000248	0.000696	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000247	0.000695	CcSEcCtD
Lercanidipine—Constipation—Docetaxel—ovarian cancer	0.000247	0.000694	CcSEcCtD
Lercanidipine—Asthenia—Paclitaxel—ovarian cancer	0.000245	0.000687	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—ovarian cancer	0.000242	0.000681	CcSEcCtD
Lercanidipine—Pruritus—Paclitaxel—ovarian cancer	0.000241	0.000678	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—ovarian cancer	0.00024	0.000675	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00024	0.000674	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—ovarian cancer	0.000239	0.000671	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—ovarian cancer	0.000239	0.000671	CcSEcCtD
Lercanidipine—Feeling abnormal—Docetaxel—ovarian cancer	0.000238	0.000669	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—ovarian cancer	0.000237	0.000666	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—ovarian cancer	0.000237	0.000665	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000236	0.000664	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—ovarian cancer	0.000236	0.000662	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000236	0.000662	CcSEcCtD
Lercanidipine—Tension—Epirubicin—ovarian cancer	0.000234	0.000658	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—ovarian cancer	0.000234	0.000657	CcSEcCtD
Lercanidipine—Diarrhoea—Paclitaxel—ovarian cancer	0.000233	0.000655	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—ovarian cancer	0.000232	0.000652	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—ovarian cancer	0.00023	0.000647	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—ovarian cancer	0.00023	0.000645	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—ovarian cancer	0.000229	0.000644	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000229	0.000643	CcSEcCtD
Lercanidipine—Abdominal pain—Docetaxel—ovarian cancer	0.000228	0.000642	CcSEcCtD
Lercanidipine—Body temperature increased—Docetaxel—ovarian cancer	0.000228	0.000642	CcSEcCtD
Lercanidipine—Dizziness—Paclitaxel—ovarian cancer	0.000225	0.000633	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—ovarian cancer	0.000225	0.000632	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—ovarian cancer	0.000224	0.00063	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—ovarian cancer	0.000222	0.000625	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000222	0.000622	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—ovarian cancer	0.000221	0.000621	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—ovarian cancer	0.000221	0.000621	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—ovarian cancer	0.000221	0.00062	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—ovarian cancer	0.000217	0.000609	CcSEcCtD
Lercanidipine—Vomiting—Paclitaxel—ovarian cancer	0.000217	0.000609	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—ovarian cancer	0.000216	0.000608	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—ovarian cancer	0.000215	0.000605	CcSEcCtD
Lercanidipine—Rash—Paclitaxel—ovarian cancer	0.000215	0.000604	CcSEcCtD
Lercanidipine—Dermatitis—Paclitaxel—ovarian cancer	0.000215	0.000603	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—ovarian cancer	0.000215	0.000603	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—ovarian cancer	0.000214	0.000603	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—ovarian cancer	0.000214	0.000602	CcSEcCtD
Lercanidipine—Headache—Paclitaxel—ovarian cancer	0.000214	0.0006	CcSEcCtD
Lercanidipine—Hypersensitivity—Docetaxel—ovarian cancer	0.000213	0.000598	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—ovarian cancer	0.000212	0.000597	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—ovarian cancer	0.000211	0.000593	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—ovarian cancer	0.00021	0.00059	CcSEcCtD
Lercanidipine—Cough—Epirubicin—ovarian cancer	0.000208	0.000585	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—ovarian cancer	0.000208	0.000585	CcSEcCtD
Lercanidipine—Asthenia—Docetaxel—ovarian cancer	0.000207	0.000582	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000205	0.000576	CcSEcCtD
Lercanidipine—Pruritus—Docetaxel—ovarian cancer	0.000204	0.000574	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—ovarian cancer	0.000204	0.000574	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—ovarian cancer	0.000203	0.000571	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—ovarian cancer	0.000203	0.000571	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—ovarian cancer	0.000203	0.000571	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—ovarian cancer	0.000203	0.000569	CcSEcCtD
Lercanidipine—Nausea—Paclitaxel—ovarian cancer	0.000202	0.000569	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000202	0.000567	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—ovarian cancer	0.000201	0.000564	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—ovarian cancer	0.000199	0.00056	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—ovarian cancer	0.000199	0.000559	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—ovarian cancer	0.000198	0.000558	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—ovarian cancer	0.000198	0.000557	CcSEcCtD
Lercanidipine—Diarrhoea—Docetaxel—ovarian cancer	0.000198	0.000555	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—ovarian cancer	0.000196	0.000552	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—ovarian cancer	0.000195	0.000549	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000194	0.000546	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—ovarian cancer	0.000193	0.000542	CcSEcCtD
Lercanidipine—Shock—Epirubicin—ovarian cancer	0.000192	0.000539	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—ovarian cancer	0.000191	0.000537	CcSEcCtD
Lercanidipine—Dizziness—Docetaxel—ovarian cancer	0.000191	0.000537	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000191	0.000536	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—ovarian cancer	0.00019	0.000534	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—ovarian cancer	0.000189	0.000532	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000188	0.000529	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—ovarian cancer	0.000188	0.000528	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—ovarian cancer	0.000188	0.000528	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—ovarian cancer	0.000188	0.000528	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—ovarian cancer	0.000187	0.000527	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000187	0.000525	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—ovarian cancer	0.000186	0.000522	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—ovarian cancer	0.000186	0.000522	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—ovarian cancer	0.000184	0.000517	CcSEcCtD
Lercanidipine—Vomiting—Docetaxel—ovarian cancer	0.000184	0.000516	CcSEcCtD
Lercanidipine—Rash—Docetaxel—ovarian cancer	0.000182	0.000512	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—ovarian cancer	0.000182	0.000512	CcSEcCtD
Lercanidipine—Dermatitis—Docetaxel—ovarian cancer	0.000182	0.000511	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—ovarian cancer	0.000182	0.000511	CcSEcCtD
Lercanidipine—Headache—Docetaxel—ovarian cancer	0.000181	0.000509	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000178	0.000499	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—ovarian cancer	0.000177	0.000498	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000177	0.000497	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000177	0.000496	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—ovarian cancer	0.000176	0.000495	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—ovarian cancer	0.000176	0.000494	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—ovarian cancer	0.000175	0.000492	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—ovarian cancer	0.000175	0.000492	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000174	0.00049	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—ovarian cancer	0.000174	0.000488	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—ovarian cancer	0.000173	0.000487	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—ovarian cancer	0.000172	0.000483	CcSEcCtD
Lercanidipine—Nausea—Docetaxel—ovarian cancer	0.000172	0.000482	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—ovarian cancer	0.000172	0.000482	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—ovarian cancer	0.000169	0.000476	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—ovarian cancer	0.000168	0.000473	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000168	0.000473	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—ovarian cancer	0.000168	0.000472	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—ovarian cancer	0.000167	0.000468	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000164	0.000462	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—ovarian cancer	0.000163	0.000458	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—ovarian cancer	0.000162	0.000455	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—ovarian cancer	0.000161	0.000452	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—ovarian cancer	0.000161	0.000451	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—ovarian cancer	0.00016	0.00045	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000159	0.000448	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—ovarian cancer	0.000159	0.000446	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—ovarian cancer	0.000157	0.00044	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000156	0.000437	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—ovarian cancer	0.000155	0.000437	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—ovarian cancer	0.000155	0.000435	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—ovarian cancer	0.000154	0.000433	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—ovarian cancer	0.000154	0.000433	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—ovarian cancer	0.000154	0.000433	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000149	0.000417	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000147	0.000414	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—ovarian cancer	0.000144	0.000403	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—ovarian cancer	0.000143	0.000402	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—ovarian cancer	0.000143	0.0004	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—ovarian cancer	0.000143	0.0004	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—ovarian cancer	0.00014	0.000393	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—ovarian cancer	0.000138	0.000387	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—ovarian cancer	0.000133	0.000375	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000133	0.000373	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—ovarian cancer	0.000129	0.000363	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—ovarian cancer	0.000129	0.000362	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—ovarian cancer	0.000128	0.000358	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—ovarian cancer	0.000124	0.000348	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—ovarian cancer	0.000123	0.000347	CcSEcCtD
Lercanidipine—Rash—Epirubicin—ovarian cancer	0.000123	0.000345	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—ovarian cancer	0.000123	0.000345	CcSEcCtD
Lercanidipine—Headache—Epirubicin—ovarian cancer	0.000122	0.000343	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—ovarian cancer	0.000119	0.000335	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—ovarian cancer	0.000116	0.000325	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—ovarian cancer	0.000115	0.000322	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—ovarian cancer	0.000114	0.000319	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—ovarian cancer	0.000114	0.000319	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—ovarian cancer	0.000113	0.000317	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—ovarian cancer	0.000107	0.000301	CcSEcCtD
